Selected research
Market Structure
Global Adult and Pediatric Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Adult and Pediatric Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Adult and Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Adult and Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Adult and Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Adult and Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Adult and Pediatric Vaccines include Sanofi, Johnson and Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Sinovac Biotech, AstraZeneca and Takeda Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Adult and Pediatric Vaccines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Adult and Pediatric Vaccines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Adult and Pediatric Vaccines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Adult and Pediatric Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.
Adult and Pediatric Vaccines Segment by Company
Sanofi
Johnson and Johnson
Novartis
Merck
Pfizer
GlaxoSmithKline
Sinovac Biotech
AstraZeneca
Takeda Pharmaceutical
LG Life Sciences
Bavarian Nordic
Adult and Pediatric Vaccines Segment by Type
Adult Vaccines
Pediatric Vaccines
Adult and Pediatric Vaccines Segment by Application
Hospitals
Medical Care Centers
Others
Adult and Pediatric Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult and Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult and Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult and Pediatric Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Adult and Pediatric Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Adult and Pediatric Vaccines industry.
Chapter 3: Detailed analysis of Adult and Pediatric Vaccines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adult and Pediatric Vaccinesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Adult Vaccines
- Pediatric Vaccines
Applications
- Hospitals
- Medical Care Centers
- Others
Companies covered
- Sanofi
- Johnson and Johnson
- Novartis
- Merck
- Pfizer
- GlaxoSmithKline
- Sinovac Biotech
- AstraZeneca
- Takeda Pharmaceutical
- LG Life Sciences
- Bavarian Nordic
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Adult and Pediatric Vaccines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Adult Vaccines
- 1.2.3 Pediatric Vaccines
- 1.3 Market Analysis by Application
- 1.3.1 Global Adult and Pediatric Vaccines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Medical Care Centers
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Adult and Pediatric Vaccines Growth Trends by Region
- 1.5.1 Global Adult and Pediatric Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Adult and Pediatric Vaccines Market Size by Region (2021-2026)
- 1.5.3 Adult and Pediatric Vaccines Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Adult and Pediatric Vaccines Market Dynamics
- 2.1 Adult and Pediatric Vaccines Industry Trends
- 2.2 Adult and Pediatric Vaccines Industry Drivers
- 2.3 Adult and Pediatric Vaccines Industry Opportunities and Challenges
- 2.4 Adult and Pediatric Vaccines Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Adult and Pediatric Vaccines Revenue by Company (2021-2026)
- 3.2 Global Adult and Pediatric Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Adult and Pediatric Vaccines Key Company Head office and Area Served
- 3.4 Global Adult and Pediatric Vaccines Company, Product Type & Application
- 3.5 Global Adult and Pediatric Vaccines Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Adult and Pediatric Vaccines Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Adult and Pediatric Vaccines Players Market Share by Revenue in 2025
- 3.6.3 2025 Adult and Pediatric Vaccines Tier 1, Tier 2, and Tier 3
4 Adult and Pediatric Vaccines Market by Type
- 4.1 Global Adult and Pediatric Vaccines Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Adult and Pediatric Vaccines Market Size by Type (2021-2032)
- 4.3 Global Adult and Pediatric Vaccines Market Size Share by Type (2021-2032)
5 Adult and Pediatric Vaccines Market by Application
- 5.1 Global Adult and Pediatric Vaccines Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Adult and Pediatric Vaccines Market Size by Application (2021-2032)
- 5.3 Global Adult and Pediatric Vaccines Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Sanofi Adult and Pediatric Vaccines Product Portfolio
- 6.1.5 Sanofi Recent Developments
- 6.2 Johnson and Johnson
- 6.2.1 Johnson and Johnson Company Information
- 6.2.2 Johnson and Johnson Business Overview
- 6.2.3 Johnson and Johnson Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Johnson and Johnson Adult and Pediatric Vaccines Product Portfolio
- 6.2.5 Johnson and Johnson Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Novartis Adult and Pediatric Vaccines Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Merck
- 6.4.1 Merck Company Information
- 6.4.2 Merck Business Overview
- 6.4.3 Merck Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Merck Adult and Pediatric Vaccines Product Portfolio
- 6.4.5 Merck Recent Developments
- 6.5 Pfizer
- 6.5.1 Pfizer Company Information
- 6.5.2 Pfizer Business Overview
- 6.5.3 Pfizer Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Pfizer Adult and Pediatric Vaccines Product Portfolio
- 6.5.5 Pfizer Recent Developments
- 6.6 GlaxoSmithKline
- 6.6.1 GlaxoSmithKline Company Information
- 6.6.2 GlaxoSmithKline Business Overview
- 6.6.3 GlaxoSmithKline Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GlaxoSmithKline Adult and Pediatric Vaccines Product Portfolio
- 6.6.5 GlaxoSmithKline Recent Developments
- 6.7 Sinovac Biotech
- 6.7.1 Sinovac Biotech Company Information
- 6.7.2 Sinovac Biotech Business Overview
- 6.7.3 Sinovac Biotech Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Sinovac Biotech Adult and Pediatric Vaccines Product Portfolio
- 6.7.5 Sinovac Biotech Recent Developments
- 6.8 AstraZeneca
- 6.8.1 AstraZeneca Company Information
- 6.8.2 AstraZeneca Business Overview
- 6.8.3 AstraZeneca Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 AstraZeneca Adult and Pediatric Vaccines Product Portfolio
- 6.8.5 AstraZeneca Recent Developments
- 6.9 Takeda Pharmaceutical
- 6.9.1 Takeda Pharmaceutical Company Information
- 6.9.2 Takeda Pharmaceutical Business Overview
- 6.9.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Takeda Pharmaceutical Adult and Pediatric Vaccines Product Portfolio
- 6.9.5 Takeda Pharmaceutical Recent Developments
- 6.10 LG Life Sciences
- 6.10.1 LG Life Sciences Company Information
- 6.10.2 LG Life Sciences Business Overview
- 6.10.3 LG Life Sciences Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 LG Life Sciences Adult and Pediatric Vaccines Product Portfolio
- 6.10.5 LG Life Sciences Recent Developments
- 6.11 Bavarian Nordic
- 6.11.1 Bavarian Nordic Company Information
- 6.11.2 Bavarian Nordic Business Overview
- 6.11.3 Bavarian Nordic Adult and Pediatric Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Bavarian Nordic Adult and Pediatric Vaccines Product Portfolio
- 6.11.5 Bavarian Nordic Recent Developments
7 North America
- 7.1 North America Adult and Pediatric Vaccines Market Size (2021-2032)
- 7.2 North America Adult and Pediatric Vaccines Market Size by Type
- 7.2.1 North America Adult and Pediatric Vaccines Market Size by Type (2021-2026)
- 7.2.2 North America Adult and Pediatric Vaccines Market Size by Type (2027-2032)
- 7.2.3 North America Adult and Pediatric Vaccines Market Share by Type (2021-2032)
- 7.3 North America Adult and Pediatric Vaccines Market Size by Application
- 7.3.1 North America Adult and Pediatric Vaccines Market Size by Application (2021-2026)
- 7.3.2 North America Adult and Pediatric Vaccines Market Size by Application (2027-2032)
- 7.3.3 North America Adult and Pediatric Vaccines Market Share by Application (2021-2032)
- 7.4 North America Adult and Pediatric Vaccines Market Size by Country
- 7.4.1 North America Adult and Pediatric Vaccines Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 7.4.3 North America Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 7.4.4 North America Adult and Pediatric Vaccines Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Adult and Pediatric Vaccines Market Size (2021-2032)
- 8.2 Europe Adult and Pediatric Vaccines Market Size by Type
- 8.2.1 Europe Adult and Pediatric Vaccines Market Size by Type (2021-2026)
- 8.2.2 Europe Adult and Pediatric Vaccines Market Size by Type (2027-2032)
- 8.2.3 Europe Adult and Pediatric Vaccines Market Share by Type (2021-2032)
- 8.3 Europe Adult and Pediatric Vaccines Market Size by Application
- 8.3.1 Europe Adult and Pediatric Vaccines Market Size by Application (2021-2026)
- 8.3.2 Europe Adult and Pediatric Vaccines Market Size by Application (2027-2032)
- 8.3.3 Europe Adult and Pediatric Vaccines Market Share by Application (2021-2032)
- 8.4 Europe Adult and Pediatric Vaccines Market Size by Country
- 8.4.1 Europe Adult and Pediatric Vaccines Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 8.4.3 Europe Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 8.4.4 Europe Adult and Pediatric Vaccines Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Adult and Pediatric Vaccines Market Size (2021-2032)
- 9.2 China Adult and Pediatric Vaccines Market Size by Type
- 9.2.1 China Adult and Pediatric Vaccines Market Size by Type (2021-2026)
- 9.2.2 China Adult and Pediatric Vaccines Market Size by Type (2027-2032)
- 9.2.3 China Adult and Pediatric Vaccines Market Share by Type (2021-2032)
- 9.3 China Adult and Pediatric Vaccines Market Size by Application
- 9.3.1 China Adult and Pediatric Vaccines Market Size by Application (2021-2026)
- 9.3.2 China Adult and Pediatric Vaccines Market Size by Application (2027-2032)
- 9.3.3 China Adult and Pediatric Vaccines Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Adult and Pediatric Vaccines Market Size (2021-2032)
- 10.2 Asia Adult and Pediatric Vaccines Market Size by Type
- 10.2.1 Asia Adult and Pediatric Vaccines Market Size by Type (2021-2026)
- 10.2.2 Asia Adult and Pediatric Vaccines Market Size by Type (2027-2032)
- 10.2.3 Asia Adult and Pediatric Vaccines Market Share by Type (2021-2032)
- 10.3 Asia Adult and Pediatric Vaccines Market Size by Application
- 10.3.1 Asia Adult and Pediatric Vaccines Market Size by Application (2021-2026)
- 10.3.2 Asia Adult and Pediatric Vaccines Market Size by Application (2027-2032)
- 10.3.3 Asia Adult and Pediatric Vaccines Market Share by Application (2021-2032)
- 10.4 Asia Adult and Pediatric Vaccines Market Size by Country
- 10.4.1 Asia Adult and Pediatric Vaccines Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 10.4.3 Asia Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 10.4.4 Asia Adult and Pediatric Vaccines Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Type
- 11.2.1 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Adult and Pediatric Vaccines Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Application
- 11.3.1 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Adult and Pediatric Vaccines Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Country
- 11.4.1 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Adult and Pediatric Vaccines Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst